Intensivist | Researcher | Educator | Film Maker https://xitter.cf/t.co/baAJRrUhSa https://xitter.cf/t.co/ozZD00mRG2

Brisbane, Queensland
Joined August 2010
Prof Kiran Shekar retweeted
Co-sign 💯 Long rounds are diagnostic of a bad attending.
5
16
1
139
29,030
Prof Kiran Shekar retweeted
Kinetics of sevoflurane vaporized directly in #ECMO membrane lung  🔬ex-vivo trials using circuits primed with Ringer’s lactate; sevoflurane vaporized at concentrations of 1–8% with SGF of 1–10 L/min.  💨 sevoflurane effectively crossed PMP membranes, rapidly reaching reproducible peak concentrations to values consistent with clinical targets for deep sedation; clearance increased significantly with higher SGF  ⚠️ environmental concentrations well below occupational safety thresholds  Delivering sevoflurane vaporized directly into ECMO circuits feasible/safe alternative sedative strategy. These results provide a robust foundation for translating this into pilot clinical trial aimed at optimizing ECMO sedation with inhaled sevoflurane in patients with severe ARDS. 🔓 rdcu.be/fk2xq
10
21
1,614
Prof Kiran Shekar retweeted
#ECMO #TEG #ROTEM #Hemostasis ⚖️ ECMO is a high-stakes balancing act — thrombosis on one side, bleeding on the other. 🩸 Are conventional coagulation tests enough for such complex physiology? 🧪 Our narrative review explores how point-of-care viscoelastic assays (TEG/ROTEM) may redefine anticoagulation monitoring in ECMO. Link: thieme-connect.de/products/e… 📚 Current evidence, practical challenges, and where the field is heading — all in one review.
2
15
40
2,430
Prof Kiran Shekar retweeted
Guideline on #ECMO training. @asaiojournal Safety. Method. Quality. Evaluation. Competence.
ELSO 2025 guideline on #ECMO training & continuing education 🎓 methodologies 📋 minimum standards for initial/ongoing training, simulation, case volume, developing instructors 📜 assessment /certification 🎓 becoming endorsed training center 🔓bit.ly/3NzTwdd
7
16
2,260
Prof Kiran Shekar retweeted
SAVECMO study, consensus of international experts on key aspects of cannula-site infections complicating peripheral #ECMO: 🔍 Delphi study involving 39 international #ECLS experts definition 🩺 suspicion & methodology for diagnosis 🧫 bacteriology 💉 treatment & treatment failure ⚠️ preventive measures #FOAMcc #FOAMecmo 🔗 rdcu.be/eZd0g
1
28
2
60
5,364
Abstract submissions for @APELSOorg 2026 are now open: apelso2026.jp/callforpapers.… 👉Abstract submission deadline: February 14, 2026 👉Notification of acceptance: By the end of March
1
1
126
Prof Kiran Shekar retweeted
A study of >2,000 #ECMO patients in #ANZ found that #frailty was not associated with poorer outcomes in both long- and short-term follow up. To learn more about the study follow the link: link.springer.com/article/10…
3
1
4
381
Prof Kiran Shekar retweeted
Frailty & outcomes after #ECMO 🔍 cohort study across 116 🇦🇺 🇳🇿 ICUs 🔎 > 2K pts (2018-2024); frailty in 12.2% 🪦 1y mortality 41.9% w/o, 42.1% w frailty; results consistent across sensitivity + subgroup analyses Frailty not associated with short or long-term mortality among #ECLS patients: a reflection of eligibility patterns (selection practices + candidacy)? #FOAMcc #FOAMecmo @Crit_Care 🔓 rdcu.be/eWWRx
13
1
27
2,468
Prof Kiran Shekar retweeted
Permissive hypercapnia in acute severe respiratory failure: should we target PaCO2, pH or both?? Safe thresholds in critically ill? 🩺mechanisms & management of hypercapnia requiring IMV 🫁 impact of hypercapnia on outcomes 🫁 🫀🧠significant physiological effects: RV & pulmonary circulation, brain & other organs Hypercapnic acidemia during lung-protective MV may have significant consequences, and perhaps should not be a goal per se, but prompt early consideration of adjunctive therapies. Open access #FOAMcc 🔓 bit.ly/49TxOY8
95
222
18,027
Prof Kiran Shekar retweeted
#ECMO following aortic surgery ⚖️ pts undergoing aortic operations younger, with more emergencies, longer cross-clamp times, and more postoperative bleedings + stroke 🪦 mortality (8%) higher vs other groups, but not enough to consider aortic surgery as contraindication; 49.9% on-ECLS mortality. Emergency status did not affect mortality Better complication prevention pivotal to improve outcomes, particularly bleeding & neurological events, among most critical factors for in-hospital outcomes: 🩸 strategies as standardized anticoagulation protocols, early coagulation monitoring, meticulous hemostasis (& delayed chest closure when appropriate) essential 🧠 individualized cerebral protection strategies, careful perfusion pressure management, preop cerebrovascular imaging should be considered, particularly, to reduce stroke risk @asaiojournal 🔗 bit.ly/49jJAMM
8
20
1,396
Our latest blog is out - Faith, Evidence and the Stars: The ANDROMEDA‑SHOCK‑2 Trial criticalcarereviews.com/blog…
2
76
6
185
51,326
Prof Kiran Shekar retweeted
Variability in adult VV #ECMO candidacy: 🔍 international survey: global disparities observed! 📋 82% centers reported formal inclusion/exclusion criteria; very few shared identical contraindications 🚦 95% have absolute contraindications to initiating ECMO as bridge to recovery; most common severe neurologic injury and disseminated malignancy ⚖️ clinician judgment perceived as equally or more important than institutional guidelines in most center ⚖️ inconsistent decisions for clinically identical patients reported by over half of responding centers 🔍< ½ centers routinely reviewed candidacy decisions Some inconsistencies expected (likely appropriate), but extent suggests significant need/opportunities for more standardized, evidence-based approaches to improve consistency & equity in ECMO allocation @CritCareMed 🔗 bit.ly/4n7zmmg
16
1
41
5,892
Prof Kiran Shekar retweeted
EARY BIRD OFFER ENDING Register Fellows , Nurses.m @ECMO_Lakshmi @AparnaHoskote @KrKrramanathan @808dawnpatrol
3
3
313
Prof Kiran Shekar retweeted
Had the privilege of working with Dr Bishoy Zakhary, @KrKrramanathan, @kshekar01 and @ELSOeducation team on #simulation-based education in its implementation in #ECMO. Excited to see what the future holds in this rapidly developing field!
Simulation-based education for #ECMO & strategies for implementation: a systematic scoping review 🎓 SBE beneficial, improving competency scores, confidence, teamwork, troubleshooting, outcomes as times to critical actions and cannulation 🎓 retention of knowledge and skills over time unclear; regular simulation training may be beneficial 🎓 establishing standardized ECMO curricula, of which SBE should be a core component, crucial 🔗 bit.ly/48P6xYj
1
7
531
Prof Kiran Shekar retweeted
Simulation-based education for #ECMO & strategies for implementation: a systematic scoping review 🎓 SBE beneficial, improving competency scores, confidence, teamwork, troubleshooting, outcomes as times to critical actions and cannulation 🎓 retention of knowledge and skills over time unclear; regular simulation training may be beneficial 🎓 establishing standardized ECMO curricula, of which SBE should be a core component, crucial 🔗 bit.ly/48P6xYj
5
1
19
1,986
Prof Kiran Shekar retweeted
Closing #EACTS2023 with another study from PELS database: 26% of postcardiotomy #ECLS happen after emergency cardiac surgery in patients with #coronary or #aortic disease. Do not be afraid to use this tool properly in emergency patients! @EACTS @ELSOOrg @kshekar01 @JaeSeungJUNG1
5
12
968
Prof Kiran Shekar retweeted
Optimal transfusion threshold for VA #ECMO?? 🔍OBLEX study data: 534 patients/12 centres in 🇦🇺🇪🇺🇺🇸, 2019-22 ⚖️ emulated target trial comparing liberal (transfusion initiated at Hb ≥ 9 g/dL) vs restrictive practice ( ≤ 7g/dL) 🪦46% in hospital mortality 🩸liberal transfusion practice demonstrated modest survival advantage within first 2 #ECLS days; no apparent benefit beyond day 3 @Crit_Care rdcu.be/eBqR2
1
9
25
2,433
Prof Kiran Shekar retweeted
#ECLS for adult patients with #ARDS ⚙️ technical aspects 📚 evidence for VV #ECMO & #ECCO2R 🫁 indications & timing 🩺 clinical management 🚦special considerations 🏥 centre volume, logistics, hospital networks 🗺️ ECMO during respiratory pandemics 🔗 liberation from ECMO & outcomes 🔮 future research #FOAMcc #FOAMecmo 🔓 rdcu.be/ezDWp
37
1
102
11,017
Prof Kiran Shekar retweeted
💊ECMO presents unique challenges complicating pharmacotherapy. Here position paper providing focused review on evidence/knowledge gaps & identifying key research priorities: 🗝️ PK/PD reporting 🗝️ interactions between #ECLS & #RRT 🗝️ antimicrobial dosing 🗝️ analgesia and sedation for pain/agitation 🗝️ sedation/NMBAs for increased work of breathing 🗝️ anticoagulation @CritCareMed 🖇️ bit.ly/4m0alKi
21
1
58
3,872
Prof Kiran Shekar retweeted
What is the impact of #LV #unloading during #ECPR? Target trial emulation using #ELSO registry: 🏥 300 centres, 621 matched pairs ❌ LV unloading NOT a/w survival benefits 💘 More CNS, CVS, and metabolic complications, and longer #ECMO durations! link.springer.com/article/10…
8
11
1,404